The death of Prince—likely the result of prescription opioid abuse—is the latest manifestation of what has been called a national opioid epidemic. Now an advisory panel has unanimously recommended that the FDA make mandatory a currently elective program—Risk Evaluation and Mitigation Strategies, or REMS— designed to educate physicians about the risks of opioid misuse and abuse. The advisory panel’s recommendation is an example of regulatory overreach—based on little or no evidence—that the FDA should reject.
Read Full Article »
